EFFECTS OF HYDROXYCHLOROQUINE PLUS FAVIPIRAVIR TREATMENT ON THE CLINICAL COURSE AND BIOMARKERS IN HOSPITALIZED COVID-19 PATIENTS WITH PNEUMONIA

BACKGROUND: The novel coronavirus disease 2019 (COVID-19) has a broad spectrum of clinical manifestations, the most common serious clinical manifestation of the coronavirus infection being pneumonia. Unfortunately, the optimal treatment approach is still uncertain. However, many studies have been co...

Descripción completa

Detalles Bibliográficos
Autores principales: Delen, Leman Acun, Gok, Abdullah, Kasapoglu, Umut Sabri, Cagasar, Ozlem, Gok, Zarife, Berber, Nurcan, Derya, Serdar, Tetik, Bora
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Sestre Milosrdnice University Hospital and Institute of Clinical Medical Research, Vinogradska cesta c. 29 Zagreb 2022
Materias:
Original Scientific Papers
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10364115/
https://www.ncbi.nlm.nih.gov/pubmed/37492367
http://dx.doi.org/10.20471/acc.2022.61.03.05

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10364115/
https://www.ncbi.nlm.nih.gov/pubmed/37492367
http://dx.doi.org/10.20471/acc.2022.61.03.05

Ejemplares similares